Brind.

Regeneron Pharmaceuticals filed required reports with the SEC regarding institutional holdings on September 8, 2026.

1 report, 1 independent Updated Sep 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Regeneron Pharmaceuticals SEC

Keep exploring

The entities involved

Regeneron Pharmaceuticals
American pharmaceutical company
- Regeneron Pharmaceuticals and Wave Life Sciences are being compared as healthcare companies.Sun 14:10
SEC
Slovak company
- DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
- The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

PIMCO filed reports with the SEC regarding institutional holdings on September 6, 2026.Sep 6
Kiniksa Pharmaceuticals International filed required documents with the SEC regarding institutional investment activity.Sep 11
Ranpak filed 13F reports regarding institutional holdings with the SEC on August 16, 2026.Aug 16
Clorox filed required institutional holdings reports with the SEC on August 9, 2026.Aug 9
Quarto d'Altino filed required disclosures with the SEC regarding institutional holdings on August 16, 2026.Aug 16

Coverage

Newest first; wire copies grouped

Sep 8tickerreport.com